Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cerium oxide nanoparticles - BioCurity

Next Previous
X
Search
Drug Profile

Cerium oxide nanoparticles - BioCurity

Latest Information Update: 01 Apr 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioCurity Pharmaceuticals
  • Class Antineoplastics; Inorganic carbon compounds; Oxides; Radioprotectives
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Radiation injuries

Most Recent Events

  • 01 Apr 2022 BioCurity Pharmaceuticals received issuance in Australia, Hong Kong and Mexico use of cerium oxide nanoparticles for the protection against radiation therapy for cancer patients receiving a combination therapy
  • 29 Mar 2022 BioCurity Pharmaceuticals receives notice of allowance allowance for cerium oxide nanoparticles for the protection against radiation therapy for cancer patients receiving a combination therapy in USA
  • 15 Mar 2022 BioCurity Pharmaceuticals has patent protection In USA for use of cerium oxide nanoparticles for the protection of skin or salivary gland for cancer patients undergoing radiation therapy

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top